Il Levetiracetam nel trattamento delle crisi parziali in pazienti resistenti al Topiramato

S. D&apos;Arcangelo; A. M. Bacchetta; G. Egeo; A. T. Giallonardo; F. Randi; N. Vanacore; M. R. De Feo

Il Levetiracetam nel trattamento delle crisi parziali in pazienti resistenti al Topiramato

Translated title of the contribution: Levetiracetam for the treatment of epileptic partial seizures in Topiramate resistant patients

S. D'Arcangelo, A. M. Bacchetta, G. Egeo, A. T. Giallonardo, F. Randi, N. Vanacore, M. R. De Feo

Istituto San Raffaele Pisana

Research output: Contribution to journal › Article › peer-review

Abstract

Purpose of the study was the identification of parameters predictive of efficacy of Levetiracetam (LEV) administered in a group of 75 patients affected by epileptic partial seizures and resistent/intolerant to Topiramate treatment. Only the dose <2000 mg and the treatment lasting more than 10 months resulted significantly correlated with a favorable response to LEV.

Translated title of the contribution	Levetiracetam for the treatment of epileptic partial seizures in Topiramate resistant patients
Original language	Italian
Pages (from-to)	183-185
Number of pages	3
Journal	Bollettino - Lega Italiana contro l'Epilessia
Issue number	121-122
Publication status	Published - Jul 2003

ASJC Scopus subject areas

Clinical Neurology

Fingerprint Dive into the research topics of 'Levetiracetam for the treatment of epileptic partial seizures in Topiramate resistant patients'. Together they form a unique fingerprint.

Cite this

@article{08771800bbd2485f9723a722bc892e78,

title = "Il Levetiracetam nel trattamento delle crisi parziali in pazienti resistenti al Topiramato",

abstract = "Purpose of the study was the identification of parameters predictive of efficacy of Levetiracetam (LEV) administered in a group of 75 patients affected by epileptic partial seizures and resistent/intolerant to Topiramate treatment. Only the dose <2000 mg and the treatment lasting more than 10 months resulted significantly correlated with a favorable response to LEV.",

keywords = "Epileptic Partial Seizures, Levetiracetam, Topiramate",

author = "S. D'Arcangelo and Bacchetta, {A. M.} and G. Egeo and Giallonardo, {A. T.} and F. Randi and N. Vanacore and {De Feo}, {M. R.}",

year = "2003",

month = jul,

language = "Italian",

pages = "183--185",

journal = "Bollettino - Lega Italiana contro l'Epilessia",

issn = "0394-560X",

publisher = "Lega Italiana contro l'Epilessia",

number = "121-122",

}

TY - JOUR

T1 - Il Levetiracetam nel trattamento delle crisi parziali in pazienti resistenti al Topiramato

AU - D'Arcangelo, S.

AU - Bacchetta, A. M.

AU - Egeo, G.

AU - Giallonardo, A. T.

AU - Randi, F.

AU - Vanacore, N.

AU - De Feo, M. R.

PY - 2003/7

Y1 - 2003/7

N2 - Purpose of the study was the identification of parameters predictive of efficacy of Levetiracetam (LEV) administered in a group of 75 patients affected by epileptic partial seizures and resistent/intolerant to Topiramate treatment. Only the dose <2000 mg and the treatment lasting more than 10 months resulted significantly correlated with a favorable response to LEV.

AB - Purpose of the study was the identification of parameters predictive of efficacy of Levetiracetam (LEV) administered in a group of 75 patients affected by epileptic partial seizures and resistent/intolerant to Topiramate treatment. Only the dose <2000 mg and the treatment lasting more than 10 months resulted significantly correlated with a favorable response to LEV.

KW - Epileptic Partial Seizures

KW - Levetiracetam

KW - Topiramate

UR - http://www.scopus.com/inward/record.url?scp=1242272733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1242272733&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:1242272733

SP - 183

EP - 185

JO - Bollettino - Lega Italiana contro l'Epilessia

JF - Bollettino - Lega Italiana contro l'Epilessia

SN - 0394-560X

IS - 121-122

ER -